EUVIMEDEUVIMED entdecken
Crossref

Comparative Evaluation of Nebulized Salbutamol versus Metered Dose Inhaler with Spacer in Acute Pediatric Asthma Exacerbations

Arpita Manish Patel, Hinabahen R. Chaudhary, Kamleshkumar Chamanlal Bhatiya

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Arpita Manish Patel und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute asthma exacerbations represent a significant cause of pediatric emergency department visits worldwide. While nebulized salbutamol remains the traditional delivery method, metered dose inhalers (MDI) with spacer devices offer potential advantages including cost-effectiveness and portability. This study compared the clinical efficacy and safety of nebulized salbutamol versus MDI with spacer in managing acute pediatric asthma exacerbations.

Methods

A randomized controlled trial was conducted in the pediatric emergency department involving 186 children aged 2-12 years presenting with acute asthma exacerbations. Participants were randomly assigned to receive either nebulized salbutamol (2.5-5 mg, n=94) or salbutamol via MDI with spacer (400-800 mcg, n=92). Primary outcomes included change in Pediatric Asthma Severity Score (PASS) at 60 minutes, oxygen saturation improvement, and hospitalization rates. Secondary outcomes comprised treatment duration, adverse effects, and parent satisfaction.

Results

Both groups demonstrated significant clinical improvement with no statistically significant difference in PASS reduction at 60 minutes (nebulizer: 3.8 ± 1.2 vs. MDI/spacer: 3.6 ± 1.1, p=0.241). Oxygen saturation increased comparably in both groups (nebulizer: 94.3 ± 2.1% to 97.8 ± 1.4%; MDI/spacer: 94.1 ± 2.3% to 97.6 ± 1.5%, p=0.389). Hospitalization rates were similar (nebulizer: 18.1% vs. MDI/spacer: 15.2%, p=0.584). Treatment time was significantly shorter with MDI/spacer (18.4 ± 4.2 vs. 31.7 ± 6.8 minutes, p

Zitieren

APA

Patel, A. M., Chaudhary, H. R., & Bhatiya, K. C. (2026). Comparative Evaluation of Nebulized Salbutamol versus Metered Dose Inhaler with Spacer in Acute Pediatric Asthma Exacerbations. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.210

Vancouver

Patel AM, Chaudhary HR, Bhatiya KC. Comparative Evaluation of Nebulized Salbutamol versus Metered Dose Inhaler with Spacer in Acute Pediatric Asthma Exacerbations. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.210

BibTeX
@article{Patel2026,
  author = {Patel, Arpita Manish and Chaudhary, Hinabahen R. and Bhatiya, Kamleshkumar Chamanlal},
  title = {Comparative Evaluation of Nebulized Salbutamol versus Metered Dose Inhaler with Spacer in Acute Pediatric Asthma Exacerbations},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.210}
}
Kostenlos starten →